vs
Maplebear Inc.（CART）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
Maplebear Inc.的季度营收约是ICU MEDICAL INC的1.8倍（$992.0M vs $540.7M），Maplebear Inc.净利率更高（8.2% vs -2.9%，领先11.1%），Maplebear Inc.同比增速更快（12.3% vs -14.1%），Maplebear Inc.自由现金流更多（$171.0M vs $36.0M），过去两年Maplebear Inc.的营收复合增速更高（10.0% vs -2.3%）
Maplebear Inc. 以Instacart为品牌开展业务，是总部位于美国旧金山的零售媒体及配送企业，在美国和加拿大运营生鲜杂货配送与自提服务。用户可通过官网及移动应用从合作商户订购食品杂货，在法律允许的地区还可选购酒类商品，所有订单由专属采购专员负责拣选、打包并配送上门。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
CART vs ICUI — 直观对比
营收规模更大
CART
是对方的1.8倍
$540.7M
营收增速更快
CART
高出26.5%
-14.1%
净利率更高
CART
高出11.1%
-2.9%
自由现金流更多
CART
多$135.0M
$36.0M
两年增速更快
CART
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $992.0M | $540.7M |
| 净利润 | $81.0M | $-15.7M |
| 毛利率 | 72.3% | 37.5% |
| 营业利润率 | 9.9% | 1.0% |
| 净利率 | 8.2% | -2.9% |
| 营收同比 | 12.3% | -14.1% |
| 净利润同比 | -45.3% | 34.0% |
| 每股收益（稀释后） | $0.31 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CARTICUI
| Q4 25 | $992.0M | $540.7M | ||
| Q3 25 | $939.0M | $537.0M | ||
| Q2 25 | $914.0M | $548.9M | ||
| Q1 25 | $897.0M | $604.7M | ||
| Q4 24 | $883.0M | $629.8M | ||
| Q3 24 | $852.0M | $589.1M | ||
| Q2 24 | $823.0M | $596.5M | ||
| Q1 24 | $820.0M | $566.7M |
净利润CARTICUI
| Q4 25 | $81.0M | $-15.7M | ||
| Q3 25 | $144.0M | $-3.4M | ||
| Q2 25 | $116.0M | $35.3M | ||
| Q1 25 | $106.0M | $-15.5M | ||
| Q4 24 | $148.0M | $-23.8M | ||
| Q3 24 | $118.0M | $-33.0M | ||
| Q2 24 | $61.0M | $-21.4M | ||
| Q1 24 | $130.0M | $-39.5M |
毛利率CARTICUI
| Q4 25 | 72.3% | 37.5% | ||
| Q3 25 | 73.7% | 37.4% | ||
| Q2 25 | 74.2% | 37.9% | ||
| Q1 25 | 74.8% | 34.7% | ||
| Q4 24 | 75.2% | 36.1% | ||
| Q3 24 | 75.2% | 34.8% | ||
| Q2 24 | 75.7% | 34.8% | ||
| Q1 24 | 74.9% | 32.7% |
营业利润率CARTICUI
| Q4 25 | 9.9% | 1.0% | ||
| Q3 25 | 17.7% | 2.6% | ||
| Q2 25 | 13.6% | 1.9% | ||
| Q1 25 | 12.3% | 2.1% | ||
| Q4 24 | 17.6% | 6.0% | ||
| Q3 24 | 16.2% | 1.4% | ||
| Q2 24 | 6.3% | 1.3% | ||
| Q1 24 | 17.6% | -1.9% |
净利率CARTICUI
| Q4 25 | 8.2% | -2.9% | ||
| Q3 25 | 15.3% | -0.6% | ||
| Q2 25 | 12.7% | 6.4% | ||
| Q1 25 | 11.8% | -2.6% | ||
| Q4 24 | 16.8% | -3.8% | ||
| Q3 24 | 13.8% | -5.6% | ||
| Q2 24 | 7.4% | -3.6% | ||
| Q1 24 | 15.9% | -7.0% |
每股收益（稀释后）CARTICUI
| Q4 25 | $0.31 | $-0.63 | ||
| Q3 25 | $0.51 | $-0.14 | ||
| Q2 25 | $0.41 | $1.43 | ||
| Q1 25 | $0.37 | $-0.63 | ||
| Q4 24 | $0.53 | $-0.97 | ||
| Q3 24 | $0.42 | $-1.35 | ||
| Q2 24 | $0.20 | $-0.88 | ||
| Q1 24 | $0.43 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $687.0M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.5B | $2.1B |
| 总资产 | $3.7B | $4.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CARTICUI
| Q4 25 | $687.0M | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.4B | $308.6M | ||
| Q3 24 | $1.3B | $312.5M | ||
| Q2 24 | $1.4B | $302.6M | ||
| Q1 24 | $1.5B | $251.4M |
股东权益CARTICUI
| Q4 25 | $2.5B | $2.1B | ||
| Q3 25 | $3.5B | $2.1B | ||
| Q2 25 | $3.3B | $2.1B | ||
| Q1 25 | $3.2B | $2.0B | ||
| Q4 24 | $3.1B | $2.0B | ||
| Q3 24 | $2.9B | $2.0B | ||
| Q2 24 | $3.0B | $2.0B | ||
| Q1 24 | $3.1B | $2.1B |
总资产CARTICUI
| Q4 25 | $3.7B | $4.1B | ||
| Q3 25 | $4.5B | $4.1B | ||
| Q2 25 | $4.4B | $4.1B | ||
| Q1 25 | $4.3B | $4.2B | ||
| Q4 24 | $4.1B | $4.2B | ||
| Q3 24 | $3.9B | $4.3B | ||
| Q2 24 | $4.0B | $4.3B | ||
| Q1 24 | $4.1B | $4.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.0M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $171.0M | $36.0M |
| 自由现金流率自由现金流/营收 | 17.2% | 6.6% |
| 资本支出强度资本支出/营收 | 1.2% | 4.6% |
| 现金转化率经营现金流/净利润 | 2.26× | — |
| 过去12个月自由现金流最近4个季度 | $910.0M | $91.8M |
8季度趋势，按日历期对齐
经营现金流CARTICUI
| Q4 25 | $183.0M | $60.6M | ||
| Q3 25 | $287.0M | $56.7M | ||
| Q2 25 | $203.0M | $11.2M | ||
| Q1 25 | $298.0M | $51.3M | ||
| Q4 24 | $153.0M | $40.2M | ||
| Q3 24 | $185.0M | $36.1M | ||
| Q2 24 | $244.0M | $82.0M | ||
| Q1 24 | $105.0M | $45.8M |
自由现金流CARTICUI
| Q4 25 | $171.0M | $36.0M | ||
| Q3 25 | $272.0M | $27.6M | ||
| Q2 25 | $187.0M | $-8.5M | ||
| Q1 25 | $280.0M | $36.7M | ||
| Q4 24 | $141.0M | $16.1M | ||
| Q3 24 | $171.0M | $16.2M | ||
| Q2 24 | $220.0M | $62.5M | ||
| Q1 24 | $91.0M | $29.9M |
自由现金流率CARTICUI
| Q4 25 | 17.2% | 6.6% | ||
| Q3 25 | 29.0% | 5.1% | ||
| Q2 25 | 20.5% | -1.5% | ||
| Q1 25 | 31.2% | 6.1% | ||
| Q4 24 | 16.0% | 2.6% | ||
| Q3 24 | 20.1% | 2.7% | ||
| Q2 24 | 26.7% | 10.5% | ||
| Q1 24 | 11.1% | 5.3% |
资本支出强度CARTICUI
| Q4 25 | 1.2% | 4.6% | ||
| Q3 25 | 1.6% | 5.4% | ||
| Q2 25 | 1.8% | 3.6% | ||
| Q1 25 | 2.0% | 2.4% | ||
| Q4 24 | 1.4% | 3.8% | ||
| Q3 24 | 1.6% | 3.4% | ||
| Q2 24 | 2.9% | 3.3% | ||
| Q1 24 | 1.7% | 2.8% |
现金转化率CARTICUI
| Q4 25 | 2.26× | — | ||
| Q3 25 | 1.99× | — | ||
| Q2 25 | 1.75× | 0.32× | ||
| Q1 25 | 2.81× | — | ||
| Q4 24 | 1.03× | — | ||
| Q3 24 | 1.57× | — | ||
| Q2 24 | 4.00× | — | ||
| Q1 24 | 0.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CART
| Transaction | $698.0M | 70% |
| Advertising And Other | $294.0M | 30% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
